# KCNJ1

## Overview
The KCNJ1 gene encodes the potassium inwardly rectifying channel subfamily J member 1, commonly referred to as the ROMK channel. This gene is crucial for encoding a transmembrane protein that functions as a potassium-selective channel, playing a significant role in maintaining potassium ion homeostasis, particularly in the renal system. The ROMK channel is integral to the reabsorption of potassium ions in the renal tubules, contributing to electrolyte balance and normal kidney function (Srivastava2013Identification). It is regulated by intracellular ATP levels and is sensitive to changes in cellular metabolism, which influences its role in modulating membrane excitability (Krishnan1995Isolation). Mutations in KCNJ1 are linked to Bartter syndrome type II, a condition characterized by electrolyte imbalances and renal dysfunction (Yang2022A). The channel's activity is modulated by various factors, including phosphorylation and pH, which are essential for its physiological functions in different tissues (Nakamura2001An).

## Structure
The KCNJ1 gene encodes the ROMK protein, a member of the inwardly rectifying potassium channel family, specifically the Kir1.1 channel. The primary structure of ROMK consists of two transmembrane domains, M1 and M2, and a conserved potassium selectivity filter. The cytoplasmic N-terminal domain comprises amino acids 1-82, while the C-terminal domain spans amino acids 181-391. The extracellular loop is located between amino acids 106-155 (O’Donnell2017Endoplasmic).

The secondary structure of ROMK includes alpha-helices and beta-sheets, which contribute to its functional conformation. The tertiary structure involves the folding of these elements into a functional channel, while the quaternary structure is formed by the tetramerization of four subunits, creating a functional channel (O’Donnell2017Endoplasmic).

ROMK is subject to post-translational modifications, such as phosphorylation, which can affect its activity. Specific mutations in the C-terminal domain, such as A198T, R212P, H270Y, and Y314C, are associated with type II Bartter syndrome and impact protein trafficking and stability, leading to degradation via the ER-associated degradation pathway (O’Donnell2017Endoplasmic).

## Function
The KCNJ1 gene encodes a potassium-selective channel known as ROMK, which plays a critical role in maintaining potassium ion balance in the kidneys. This channel is primarily involved in the reabsorption of potassium ions in the renal tubules, a process essential for maintaining electrolyte balance and normal kidney function (Srivastava2013Identification). In healthy human cells, ROMK channels facilitate the recycling of potassium between the cell and lumen in the thick ascending limb of Henle's loop (TAL), which is necessary for the reabsorption of NaCl (Abbas2011Functional). 

The KCNJ1-encoded channel is regulated by ATP and is sensitive to intracellular ATP levels, playing a role in sensing cellular intermediary metabolism and modulating membrane excitability (Krishnan1995Isolation). In excitable tissues, such as muscle and nervous tissues, these channels are typically closed at resting metabolic rates but become activated when cytosolic ATP concentrations decrease, such as during hypoxia or hypoglycemia (Krishnan1995Isolation). This activation leads to hyperpolarization and a decrease in membrane excitability, which can protect neurons during stress (Krishnan1995Isolation). The channel's activity is also modulated by phosphorylation and pH, contributing to its function in human proximal tubule cells (Nakamura2001An).

## Clinical Significance
Mutations in the KCNJ1 gene, which encodes the renal outer medullary potassium channel (ROMK), are associated with Bartter syndrome type II (BS II), a rare inherited renal disorder. BS II is characterized by hypokalemic metabolic alkalosis, hyperreninemia, hyperaldosteronism, and hypercalciuria, which can lead to nephrocalcinosis and nephrolithiasis (Yang2022A; Wu2022A). Patients with BS II often present with symptoms such as polyuria, polydipsia, muscle weakness, and growth retardation. The condition can begin in utero, causing fetal polyuria and polyhydramnios, and may result in premature delivery (Wu2022A).

Specific mutations in KCNJ1, such as p.C30Y and p.R22M, have been identified in patients with BS II, with the latter being a novel mutation predicted to be deleterious (Yang2022A; Wu2022A). These mutations disrupt the function of the ROMK channel, affecting potassium secretion and sodium chloride absorption in the kidney, leading to the clinical manifestations of BS II (Yang2022A; Srivastava2013Identification).

The clinical presentation of BS II can vary, with some patients experiencing transient neonatal hyperkalemia and metabolic acidosis, resembling pseudohypoaldosteronism type 1, before developing hypokalemia (Peters2002Clinical). Genetic testing, such as next-generation sequencing, is crucial for diagnosing BS II, as clinical manifestations can be variable and lead to misdiagnosis (Wu2022A).

## Interactions
KCNJ1, also known as the ROMK channel, is involved in several interactions that are crucial for its function in potassium secretion and sodium chloride absorption in the kidney. The channel's activity is regulated by intracellular pH, with gating driven by the protonation of lysine within the KRR motif, which includes amino acid residues at positions 22, 61, and 292 (Yang2022A). Mutations in KCNJ1, such as c.65G > T (p.R22M) and c.89G > A (p.C30Y), can disrupt the structure and function of the ROMK channel, affecting its interactions and stability (Yang2022A).

KCNJ1 interacts with other proteins involved in renal salt wasting and chloride transport, such as the apical Na-K-2Cl cotransporter (NKCC2), the basolateral chloride channel (ClC), a basolateral K-CL cotransporter, and the Na-K-ATPase. These interactions are essential for maintaining tubular concentrating capability and are implicated in conditions like Bartter syndrome type II (Yang2022A).

In gastric parietal cells, KCNJ1 facilitates gastric acid secretion by recycling potassium for ion exchange by the H+/K+-ATPase. It is regulated by multiple pathways, including protein kinase A (PKA), protein kinase C (PKC), intracellular pH, and PIP2 (Neverisky2016Ion).


## References


[1. (Yang2022A) Saisai Yang, Guanghui Yao, Xin Chen, Huirong Shi, Chihhong Lou, Shumin Ren, Zhihui Jiao, Cong Wang, Xiangdong Kong, and Qinghua Wu. A novel mutation of kcnj1 identified in an affected child with nephrolithiasis. BMC Nephrology, June 2022. URL: http://dx.doi.org/10.1186/s12882-022-02783-x, doi:10.1186/s12882-022-02783-x. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12882-022-02783-x)

2. (Wu2022A) A Novel Mutation of KCNJ1 Identified in an Affected Child with Nephrolithiasis. This article has 0 citations.

[3. (Neverisky2016Ion) Daniel L. Neverisky and Geoffrey W. Abbott. Ion channel–transporter interactions. Critical Reviews in Biochemistry and Molecular Biology, 51(4):257–267, April 2016. URL: http://dx.doi.org/10.3109/10409238.2016.1172553, doi:10.3109/10409238.2016.1172553. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/10409238.2016.1172553)

[4. (Srivastava2013Identification) Shalabh Srivastava, Dimin Li, Noel Edwards, Ann-M. Hynes, Katrina Wood, Mohamed Al-Hamed, Anna C. Wroe, David Reaich, Shabbir H. Moochhala, Paul A. Welling, and John A. Sayer. Identification of compound heterozygous kcnj1 mutations (encoding romk) in a kindred with bartter’s syndrome and a functional analysis of their pathogenicity. Physiological Reports, 1(6):e00160, November 2013. URL: http://dx.doi.org/10.1002/phy2.160, doi:10.1002/phy2.160. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/phy2.160)

[5. (O’Donnell2017Endoplasmic) Brighid M. O’Donnell, Timothy D. Mackie, Arohan R. Subramanya, and Jeffrey L. Brodsky. Endoplasmic reticulum–associated degradation of the renal potassium channel, romk, leads to type ii bartter syndrome. Journal of Biological Chemistry, 292(31):12813–12827, August 2017. URL: http://dx.doi.org/10.1074/jbc.m117.786376, doi:10.1074/jbc.m117.786376. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m117.786376)

[6. (Peters2002Clinical) Melanie Peters, Nikola Jeck, Stephan Reinalter, Andreas Leonhardt, Burkhard Tönshoff, G.ünter Klaus, Martin Konrad, and Hannsjörg W Seyberth. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. The American Journal of Medicine, 112(3):183–190, February 2002. URL: http://dx.doi.org/10.1016/s0002-9343(01)01086-5, doi:10.1016/s0002-9343(01)01086-5. This article has 202 citations.](https://doi.org/10.1016/s0002-9343(01)01086-5)

[7. (Krishnan1995Isolation) SantoshN. Krishnan, Trushna Desai, DavidC. Ward, and GabrielG. Haddad. Isolation and chromosomal localization of a human atp-regulated potassium channel. Human Genetics, 96(2):155–160, August 1995. URL: http://dx.doi.org/10.1007/BF00207372, doi:10.1007/bf00207372. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/BF00207372)

[8. (Nakamura2001An) Kazuyoshi Nakamura, Junko Hirano, and Manabu Kubokawa. An atp-regulated and ph-sensitive inwardly rectifying k+ channel in cultured human proximal tubule cells. The Japanese Journal of Physiology, 51(4):523–530, 2001. URL: http://dx.doi.org/10.2170/JJPHYSIOL.51.523, doi:10.2170/jjphysiol.51.523. This article has 14 citations.](https://doi.org/10.2170/JJPHYSIOL.51.523)

[9. (Abbas2011Functional) Leila Abbas, Saeed Hajihashemi, Lucy F. Stead, Gordon J. Cooper, Tracy L. Ware, Tim S. Munsey, Tanya T. Whitfield, and Stanley J. White. Functional and developmental expression of a zebrafish kir1.1 (romk) potassium channel homologue kcnj1. The Journal of Physiology, 589(6):1489–1503, March 2011. URL: http://dx.doi.org/10.1113/jphysiol.2010.200295, doi:10.1113/jphysiol.2010.200295. This article has 29 citations.](https://doi.org/10.1113/jphysiol.2010.200295)